Merrimack Announces Major Corporate Restructuring
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- Houthi attack on Saudi airport kills 12, over 300 wounded, authorities say
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
BTIG Affirms Merrimack Pharma (MACK) at 'Neutral' Amid Restructuring Plans
October 4, 2016 10:30 AM EDTBTIG affirms Merrimack Pharma (Nasdaq: MACK) with a Neutral rating following news that the company is undertaking a corporate restructuring.
BTIG commented late Monday, MACK announced a major corporate restructuring that cuts headcount by 22% and reduces $200M+ in expected expenses over the... More



